DANNCE.AI Secures $2.6M; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care November 24, 2024
DANNCE.AI Secures $2.6M; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care November 24, 2024